Addressing myelodysplastic syndrome (MDS) with big data
Addressing myelodysplastic syndrome (MDS) with big data
Milestones from the HARMONY project's first year
Israel's involvement in the HARMONY project
Bayer's involvement in the HARMONY project
Providing a policy framework for drug development
The European Research Initiative on CLL (ERIC) and HARMONY
How the HARMONY data platform works
How is big data useful, yet challenging?
FIMM and HARMONY working together
How HARMONY will help myeloma research
Making better use of the HARMONY data
MediSapiens and the involvement of smaller companies in HARMONY
Improving AML treatment through the HARMONY project
The importance of the patient perspective for HARMONY
Improving clinical trials for better drug development
A more thorough genetic analysis through HARMONY
The progress and achievents of the HARMONY project so far
Large pharmaceutical companies working together
Advice from American big data projects
How HARMONY is taking the lead for big data
The HARMONY project comes together